How Ogovy Works
Ogovy answers one question: what does this treatment cost at each dose, from every regulated UK pharmacy that publishes a price? Here is how the service is put together and how to use it.
Using the site in four steps
Where the data comes from
Prices reach the comparison in three ways: manual checks by hand, direct price access from pharmacies that provide it, and automated scans that flag movement between manual reviews. A scan never publishes on its own. A person verifies every change, and each listing carries its own last checked date. The full method, including how corrections are handled, is set out in how we track prices.
What Ogovy is not
We also do not rank on commission. Rankings come from the price data alone, and the reasoning behind that is in the independence statement.
The wider network
Ogovy is part of Medstack Ltd and covers oral weight loss treatments. Sister sites apply the same method to their own areas so each comparison stays focused rather than sprawling: Monj for Mounjaro, iGovy for Wegovy injections and Dayo for Foundayo tablets. All four share the tracking engine, the editorial standards and the charity pledge.
Built to be read by machines too
Answer engines and AI assistants increasingly answer price questions on people’s behalf, so Ogovy publishes machine readable versions of the same data it shows you, with the same timestamps and the same rights notice. That means an AI can cite current, sourced figures rather than guessing from stale scraped pages. Nothing is hidden from readers to serve machines, and nothing is exaggerated for them either.
Ogovy is operated by Medstack Ltd, company number 16439872, registered in England and Wales.
Sources referenced on this page
Linked from the text above:
- 16439872 find-and-update.company-information.service.gov.uk
Standing primary references for every Ogovy page:
- Wegovy (semaglutide) Summary of Product Characteristics and Patient Information Leaflet, electronic medicines compendium
- MHRA Drug Safety Update: GLP-1 receptor agonists
- NICE TA875: semaglutide for managing overweight and obesity
- General Pharmaceutical Council register of pharmacies
- MHRA Yellow Card scheme

